A strong pandemic defence system could reduce the chance of another COVID like pandemic in the next ten years from 27.5% to 8%

Posted on Apr 13, 2023

Airfinity’s new risk modelling, that is being presented at the Rhodes Summit in London Friday the 14th, indicates there’s a 27.5% chance that a pandemic as deadly as COVID-19 could take place in the next ten years. It also shows that had the original COVID-19 wild type been as transmissible as Omicron, more than 300.000 thousand people would have died in the UK alone, nearly three times more than was the case. 

This new risk-assessment outlines the likelihood of future pandemics under varying degrees of severity. It shows that in a worst case scenario, an avian flu type mutation that transmits from human to human could kill as many as 15.000 in a single day in the UK. 

In recent times, we have seen an increase in the frequency of virus emergence. Climate change, the rise in international travel, a growing global population and the increasing threat posed by zoonotic diseases are some of the main factors contributing to the increase in high risk outbreak incidences.

Fast vaccine roll-out, strong delivery infrastructures and other pandemic preparedness strategies are needed to significantly reduce this. Our modelling shows that the risk of a pandemic as deadly as COVID-19 in the next ten years is 71% less with these countermeasures in place. 

If effective vaccines are rolled out 100 days after the discovery of a new pathogen, the likelihood of a pandemic as deadly as COVID-19 in the next decade drops from 27.5% to 8.1%.

However, many high-risk pathogens including zika, MERS and Marburg virus don’t have approved vaccines or treatments, and existing surveillance policies are unlikely to detect a new pandemic before it is too late. This highlights the urgent need for new and data-driven pandemic preparedness measures.

Airfinity’s CEO and co-founder Rasmus Bech Hansen says, “A robust pandemic preparedness system is the world’s insurance against a COVID-19 like pandemic or something even worse. We have calculated the real risks, but also the potential risk reduction that can be achieved. This can help inform decision makers to the level of ongoing pre-emptive investment in the space to keep people safe.”

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022